| Literature DB >> 18799179 |
Ching-Ju Yeh1, Ping-Yuan Lin, Ming-Huei Liao, Hung-Jen Liu, Jeng-Woei Lee, Shu-Jun Chiu, Hsue-Yin Hsu, Wen-Ling Shih.
Abstract
PRV infection causes apoptosis in vitro and in vivo. However, the significance of PRV-induced apoptosis and its signaling pathways is still unknown. This work investigates the role of MAPK pathways in mediating PRV-induced apoptosis. Flow cytometry, apoptosis ELISA and western blotting using antibodies against cleaved caspase-3, -6 and PARP demonstrated that PRV induces apoptosis in a time- and dose-dependent manner. p38 and JNK/SAPK inhibitors significantly protected cells from PRV-induced apoptosis. Inhibitor treatment did not affect Us3a gene transcription and progeny virus production. Western blotting revealed that PRV activates p38 and JNK/SAPK signaling. Inhibition of NF-kappaB had no effect on PRV-mediated apoptosis. Non-replicative PRV failed to activate p38 and JNK/SAPK or induce apoptosis. PRV infection increases TNF-alpha transcription, translation and secretion, as well as TNF-alpha receptor expression. Inhibition of p38 and JNK/SAPK reduced PRV-induced TNF-alpha up-regulation. Neutralization assay confirmed that TNF-alpha is a key mediator involved in PRV-induced apoptosis.Entities:
Mesh:
Substances:
Year: 2008 PMID: 18799179 DOI: 10.1016/j.virol.2008.08.023
Source DB: PubMed Journal: Virology ISSN: 0042-6822 Impact factor: 3.616